The vaccination campaign continues all over the world but the research has not ended and we are working to definitively eradicate the Covid. A major breakthrough may come later this year according to Albert Bourla, Pfizer CEO. The leading pharmaceutical company in the world market could indeed distribute an experimental drug for the home treatment of Covid-19 and which can be used at the first signs of the disease.
How the anti-Covid drug works
The main objective of the company is to limit the burden of hospitals allowing positive people to take care of yourself at home with drugs like that, a turning point according to health experts. Tests for the anti-Covid drug began in March 2021 and aims for antiviral home therapy. This is a class of drugs called protease inhibitors.
But how will the anti-Covid drug work? The pill should have the ability to block enzymes to digest proteins. It will then be able to keep proteins in an inactive state. In reality, this type of treatment has already been tested with existing drugs such as remdesivir, lopinavir and ritonavir. However, no one has been able to give valid results and protect against Coronavirus because they are not compatible with the proteases of Sars-CoV-2, the virus that causes Covid-19.
Il Pfizer drug was born with the aim of fighting the Coronavirus. Protease inhibitors are used to treat other viral pathogens such as HIV and hepatitis C. If clinical trials go well and the Food and Drug Administration approves it, the drug could be distributed in the United States later this year. . The researchers hope the drug will prevent the disease from progressing and be able to prevent hospitalization.
Pfizer also at work for the vaccine on children
In addition to the drug, Pfizer is still testing the its vaccine on children aged 6 months to 11 years. Vaccinating children is key to ending the coronavirus pandemic, public health officials and infectious disease experts say. Earlier this month, the company asked the FDA to expand the vaccine's authorization to teenagers between the ages of 12 and 15. The request comes after a study that found the injection to be 100% effective.
Bourla spoke on a CNBC broadcast and said he was "very optimistic" that the FDA will also approve use for teenagers.
